Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group (Q93515282)
Jump to navigation
Jump to search
article by M Kaufmann et al published 1 August 1989 in Journal of Clinical Oncology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group |
article by M Kaufmann et al published 1 August 1989 in Journal of Clinical Oncology |
Statements
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group (English)
M Kaufmann
W Jonat
U Kleeberg
W Eiermann
F Jänicke
J Hilfrich
R Kreienberg
M Albrecht
H K Weitzel